drugset
drugset / Trial / NCT01791803

Smoking Cessation After Hospitalization for a Cardiopulmonary Illness

NCT01791803 ↗

Completed 164 enrolled North Shore Medical Center
RandomizedParallel-groupOpen-labelTreatment

Summary

Smoking-related cardiopulmonary diseases account for a large number of hospital admissions. We investigated the efficacy of hypnotherapy as an aid to a counseling-based smoking cessation program in improving quit rates of hospitalized smoking patients at 12 and 26 weeks after hospital discharge. We compared outcomes with hospitalized patients who received more conventional therapy, namely nicotine replacement therapy, or patients who decided to quit on their own. We also compared smoking cessation rates at 12 and 26 weeks after hospitalization among patients admitted with a cardiac or a pulmonary diagnosis.

Timeline

Start
2006-01
Primary completion
2009-05
Completion
2009-05

Outcome

Met primary endpoint

registry analysis (superiority or other test); Hypnotherapy vs Nicotine Replacement Therapy; Risk Ratio (RR) 2.6 (95% CI 1.1 to 11.4) NCT01791803 ↗

registry analysis (superiority or other test); Nicotine Replacement Therapy vs Hypnotherapy and Nicotine Replacement; Risk Ratio (RR) 2.4 (95% CI 1.04 to 9.7) NCT01791803 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicotine Unknown — —

Indications

No indication recorded.